A case of chronic kidney disease with thrombotic microangiopathy in a hematopoietic stem cell transplant recipient

被引:1
|
作者
Maeda, Kunihiro [1 ]
Suzuki, Keisuke [1 ]
Mizutani, Motonori [1 ]
Watanabe, Hitoshi [1 ]
Suga, Norihiro [1 ]
Kitagawa, Wataru [1 ]
Miura, Naoto [1 ]
Nishikawa, Kazuhiro [1 ]
Uchida, Kazuharu [2 ]
Imai, Hirokazu [1 ]
机构
[1] Aichi Med Univ, Sch Med, Dept Internal Med, Div Nephrol & Rheumatol, Aichi 4801195, Japan
[2] Nagoya Daini Red Cross Hosp, Dept Transplant Surg, Nagoya, Aichi 4668650, Japan
关键词
Chronic kidney disease; Hematopoietic stem cell transplantation; Kidney transplantation; Mesangiolysis; Thrombotic microangiopathy; BONE-MARROW-TRANSPLANTATION; LONG-TERM SURVIVORS; RENAL-FAILURE; RISK-FACTORS; NEPHROPATHY; MESANGIOLYSIS; PATHOLOGY;
D O I
10.1007/s10157-010-0292-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A 23-year-old Japanese man who had undergone hematopoietic stem cell transplantation for acute lymphocytic leukemia from an HLA-identical sibling 6 years earlier developed proteinuria and impaired kidney function. Kidney biopsy revealed thrombotic microangiopathy with a moderate increase in mesangial matrices and glomerular microaneurysm featuring retention of red blood cells. The patient's kidney function gradually deteriorated, requiring the institution of treatment with angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors, and progressing to continuous ambulatory peritoneal dialysis 4 years after the initial kidney biopsy. Eventually, kidney transplantation was performed with his mother as the donor. His kidney function is stable on immunosuppressive drugs at 2 years after transplantation. This report reflects the growing number of patients with chronic kidney disease with thrombotic microangiopathy all over the world.
引用
收藏
页码:474 / 478
页数:5
相关论文
共 50 条
  • [41] Therapeutic Plasma Exchange Does Not Prevent Chronic Kidney Disease in Pediatric Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience
    Sartain, Sarah E.
    Shubert, Stacey
    Wu, Men-Feng
    Srivaths, Poyyapakam
    Teruya, Jun
    Krance, Robert A.
    Martinez, Caridad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S346 - S347
  • [42] Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation
    Mii, Akiko
    Shimizu, Akira
    Masuda, Yukinari
    Fujino, Teppei
    Kaneko, Tomohiro
    Utsumi, Kouichi
    Arai, Takashi
    Ishikawa, Arimi
    Wakamatsu, Kyoko
    Tajika, Kenji
    Iino, Yasuhiko
    Katayama, Yasuo
    Fukuda, Yuh
    PATHOLOGY INTERNATIONAL, 2011, 61 (01) : 34 - 41
  • [43] HIGH INCIDENCE OF THROMBOTIC MICROANGIOPATHY IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS WITH MULTIPLE BLOODSTREAM INFECTIONS
    Grossmann, Liron
    Badia, Priscila
    Nelson, Adam
    El-Bietar, Javier
    Myers, Kasiani
    Dandoy, Christopher
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [44] Renal Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation: Involvement of Chronic Graft-Versus-Host Disease
    Mii, Akiko
    Shimizu, Akira
    Kaneko, Tomohiro
    Nakayama, Kazutaka
    Yamaguchi, Hiroki
    Tsuruoka, Shuichi
    KIDNEY INTERNATIONAL REPORTS, 2018, 3 (03): : 743 - 747
  • [45] ECULIZUMAB FOR THE TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA)
    Thampi, Sheila
    Dvorak, Christopher
    Matthay, Katherine
    Horn, Biljana
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S104 - S105
  • [46] Pulmonary Arterial Hypertension in Pediatric Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
    Jodele, Sonata
    Hirsch, Russel
    Laskin, Benjamin
    Davies, Stella
    Witte, David
    Chima, Ranjit
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : 202 - 207
  • [47] Sirolimus-related thrombotic microangiopathy in a renal transplant recipient: a case report
    Negrini, S. M.
    Durrbach, A.
    Becquemont, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 120 - 120
  • [48] Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy
    Jodele, Sonata
    Licht, Christoph
    Goebel, Jens
    Dixon, Bradley P.
    Zhang, Kejian
    Sivakumaran, Theru A.
    Davies, Stella M.
    Pluthero, Fred G.
    Lu, Lily
    Laskin, Benjamin L.
    BLOOD, 2013, 122 (12) : 2003 - 2007
  • [49] Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy
    Ardissino, Gianluigi
    Salardi, Stefania
    Berra, Silvia
    Colussi, Giacomo
    Cugno, Massimo
    Zecca, Marco
    Giglio, Fabio
    Peccatori, Jacopo
    Diral, Elisa
    Tel, Francesca
    Clivio, Alberto
    Tedeschi, Silvana
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1580 - 1582
  • [50] PULMONARY HYPERTENSION (PH) IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TMA)
    Jodele, S.
    Chima, R.
    Hor, K.
    Witte, D.
    Laskin, B. L.
    Goebel, J.
    Mayers, K. C.
    Mehta, P. A.
    Filipovich, A. H.
    Marsh, R. A.
    Grimley, M. S.
    Davies, S. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S232 - S232